VANGUARD GROUP INC 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 4:09 pm Sale | 2026-03-13 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 0 0.000% | -18,992,533 (Position Closed) | Filing |
| 2024-07-10 1:14 pm Purchase | 2024-06-28 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 18,992,533 10.000% | 943,976 (+5.23%) | Filing |
| 2024-02-13 5:01 pm Purchase | 2023-12-29 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 18,048,557 9.580% | 683,477 (+3.94%) | Filing |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 17,365,080 9.340% | 1,014,049 (+6.20%) | Filing |
| 2022-02-09 3:33 pm Sale | 2021-12-31 | 13G | BIOMARIN PHARMACEUTICAL INC BMRN | VANGUARD GROUP INC | 16,351,031 8.910% | -18,658 (-0.11%) | Filing |